| Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer M Xing, AS Alzahrani, KA Carson, D Viola, R Elisei, B Bendlova, L Yip, ... Jama 309 (14), 1493-1501, 2013 | 1040 | 2013 |
| PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside AS Alzahrani Seminars in cancer biology 59, 125-132, 2019 | 765 | 2019 |
| Association between BRAF V600E mutation and recurrence of papillary thyroid cancer M Xing, AS Alzahrani, KA Carson, YK Shong, TY Kim, D Viola, R Elisei, ... Journal of clinical oncology 33 (1), 42, 2015 | 602 | 2015 |
| Epidemiology, clinical and complications profile of diabetes in Saudi Arabia: a review TA Elhadd, AA Al-Amoudi, AS Alzahrani Annals of Saudi medicine 27 (4), 241-250, 2007 | 251 | 2007 |
| Risk stratification in differentiated thyroid cancer: from detection to final follow-up RM Tuttle, AS Alzahrani The Journal of Clinical Endocrinology & Metabolism 104 (9), 4087-4100, 2019 | 135 | 2019 |
| Long noncoding RNAs: emerging players in thyroid cancer pathogenesis AK Murugan, AK Munirajan, AS Alzahrani Endocrine-related cancer 25 (2), R59-R82, 2018 | 125 | 2018 |
| Clinical, genetic, and structural basis of congenital adrenal hyperplasia due to 11β-hydroxylase deficiency A Khattab, S Haider, A Kumar, S Dhawan, D Alam, R Romero, J Burns, ... Proceedings of the National Academy of Sciences 114 (10), E1933-E1940, 2017 | 121 | 2017 |
| Concomitant RAS, RET/PTC, or BRAF mutations in advanced stage of papillary thyroid carcinoma M Zou, EY Baitei, AS Alzahrani, FS BinHumaid, D Alkhafaji, RA Al-Rijjal, ... Thyroid 24 (8), 1256-1266, 2014 | 118 | 2014 |
| The impact of COVID-19 viral infection on the hypothalamic-pituitary-adrenal axis AS Alzahrani, N Mukhtar, A Aljomaiah, H Aljamei, A Bakhsh, N Alsudani, ... Endocrine practice 27 (2), 83-89, 2021 | 115 | 2021 |
| Leptin-R and its association with PI3K/AKT signaling pathway in papillary thyroid carcinoma S Uddin, P Bavi, AK Siraj, M Ahmed, M Al-Rasheed, AR Hussain, ... Endocrine-related cancer 17 (1), 191, 2010 | 108 | 2010 |
| TERT Promoter Mutations in Thyroid Cancer AS Alzahrani, R Alsaadi, AK Murugan, BB Sadiq Hormones and Cancer 7, 165-177, 2016 | 93 | 2016 |
| High frequency of somatic mitochondrial DNA mutations in human thyroid carcinomas and complex I respiratory defect in thyroid cancer cell lines KK Abu-Amero, AS Alzahrani, M Zou, Y Shi Oncogene 24 (8), 1455-1460, 2005 | 82 | 2005 |
| Genome‐wide expression analysis of Middle Eastern papillary thyroid cancer reveals c‐MET as a novel target for cancer therapy AK Siraj, P Bavi, J Abubaker, Z Jehan, M Sultana, F Al‐Dayel, A Al‐Nuaim, ... The Journal of pathology 213 (2), 190-199, 2007 | 71 | 2007 |
| A Novel G102E Mutation of CYP27B1 in a Large Family with Vitamin D-Dependent Rickets Type 1 AS Alzahrani, M Zou, EY Baitei, OM Alshaikh, RA Al-Rijjal, BF Meyer, ... The Journal of Clinical Endocrinology & Metabolism 95 (9), 4176-4183, 2010 | 67 | 2010 |
| Single point mutations in pediatric differentiated thyroid cancer AS Alzahrani, AK Murugan, E Qasem, M Alswailem, H Al-Hindi, Y Shi Thyroid 27 (2), 189-196, 2017 | 66 | 2017 |
| Outcome of gonadotropin therapy for male infertility due to hypogonadotrophic hypogonadism R Farhat, F Al-zidjali, AS Alzahrani Pituitary 13, 105-110, 2010 | 66 | 2010 |
| Molecular Analysis of Congenital Hypothyroidism in Saudi Arabia: SLC26A7 Mutation Is a Novel Defect in Thyroid Dyshormonogenesis M Zou, AS Alzahrani, A Al-Odaib, MA Alqahtani, O Babiker, RA Al-Rijjal, ... The Journal of Clinical Endocrinology & Metabolism 103 (5), 1889-1898, 2018 | 65 | 2018 |
| Oncogenic activation of MAP kinase by BRAF pseudogene in thyroid tumors M Zou, EY Baitei, AS Alzahrani, F Al-Mohanna, NR Farid, B Meyer, Y Shi Neoplasia 11 (1), 57-65, 2009 | 61 | 2009 |
| Frequency and predictive factors of malignancy in residual thyroid tissue and cervical lymph nodes after partial thyroidectomy for differentiated thyroid cancer AS Alzahrani, M Al Mandil, MA Chaudhary, M Ahmed, GE Mohammed Surgery 131 (4), 443-449, 2002 | 60 | 2002 |
| Comparison of differentiated thyroid cancer in children and adolescents (≤ 20 years) with young adults AS Alzahrani, D Alkhafaji, M Tuli, H Al‐Hindi, BB Sadiq Clinical Endocrinology 84 (4), 571-577, 2016 | 58 | 2016 |
